4/26
08:01 am
mgnx
MacroGenics, Inc. (NASDAQ: MGNX) is now covered by analysts at B. Riley. They set a "buy" rating and a $25.00 price target on the stock.
Low
Report
MacroGenics, Inc. (NASDAQ: MGNX) is now covered by analysts at B. Riley. They set a "buy" rating and a $25.00 price target on the stock.
4/24
03:08 am
mgnx
Harness Therapeutics Appoints Seasoned Biopharmaceutical Leader, Ms. Meenu Chhabra Karson, as Board Chair [Yahoo! Finance]
Low
Report
Harness Therapeutics Appoints Seasoned Biopharmaceutical Leader, Ms. Meenu Chhabra Karson, as Board Chair [Yahoo! Finance]
4/19
07:32 am
mgnx
We're Hopeful That MacroGenics (NASDAQ:MGNX) Will Use Its Cash Wisely [Yahoo! Finance]
Low
Report
We're Hopeful That MacroGenics (NASDAQ:MGNX) Will Use Its Cash Wisely [Yahoo! Finance]
4/9
08:09 am
mgnx
MacroGenics, Inc. (NASDAQ: MGNX) was upgraded by analysts at TD Cowen from a "hold" rating to a "buy" rating.
Medium
Report
MacroGenics, Inc. (NASDAQ: MGNX) was upgraded by analysts at TD Cowen from a "hold" rating to a "buy" rating.
4/5
03:11 am
mgnx
MacroGenics: Positive Safety Update Leads To Two Major Inflection Points In 2024 [Seeking Alpha]
Medium
Report
MacroGenics: Positive Safety Update Leads To Two Major Inflection Points In 2024 [Seeking Alpha]
4/4
10:07 am
mgnx
ARCA biopharma, Achilles Therapeutics, MSP Recovery among healthcare movers [Seeking Alpha]
Neutral
Report
ARCA biopharma, Achilles Therapeutics, MSP Recovery among healthcare movers [Seeking Alpha]
4/4
09:06 am
mgnx
MacroGenics, Inc. (NASDAQ: MGNX) had its "market outperform" rating re-affirmed by analysts at JMP Securities.
High
Report
MacroGenics, Inc. (NASDAQ: MGNX) had its "market outperform" rating re-affirmed by analysts at JMP Securities.
4/4
07:01 am
mgnx
MacroGenics gains after mid-stage data for antibody drug conjugate [Seeking Alpha]
High
Report
MacroGenics gains after mid-stage data for antibody drug conjugate [Seeking Alpha]
4/3
04:54 pm
mgnx
MacroGenics Provides Phase 2 TAMARACK Study Early Interim Safety Data and Plans for Future Disclosures [Yahoo! Finance]
High
Report
MacroGenics Provides Phase 2 TAMARACK Study Early Interim Safety Data and Plans for Future Disclosures [Yahoo! Finance]
4/3
04:30 pm
mgnx
MacroGenics Provides Phase 2 TAMARACK Study Early Interim Safety Data and Plans for Future Disclosures
High
Report
MacroGenics Provides Phase 2 TAMARACK Study Early Interim Safety Data and Plans for Future Disclosures
3/14
08:32 am
mgnx
MacroGenics, Inc. (NASDAQ:MGNX) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Medium
Report
MacroGenics, Inc. (NASDAQ:MGNX) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
3/8
06:13 pm
mgnx
MacroGenics, Inc. (NASDAQ: MGNX) was downgraded by analysts at TheStreet from a "c" rating to a "d" rating.
Low
Report
MacroGenics, Inc. (NASDAQ: MGNX) was downgraded by analysts at TheStreet from a "c" rating to a "d" rating.
3/8
12:42 am
mgnx
MacroGenics (MGNX) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
Medium
Report
MacroGenics (MGNX) Q4 2023 Earnings Call Transcript [Yahoo! Finance]
3/7
11:14 pm
mgnx
Macrogenics Inc (MGNX) Reports Strong Financial Position and Advancements in Cancer Treatment ... [Yahoo! Finance]
Medium
Report
Macrogenics Inc (MGNX) Reports Strong Financial Position and Advancements in Cancer Treatment ... [Yahoo! Finance]
3/7
06:59 pm
mgnx
MacroGenics (MGNX) Reports Q4 Loss, Lags Revenue Estimates [Yahoo! Finance]
Medium
Report
MacroGenics (MGNX) Reports Q4 Loss, Lags Revenue Estimates [Yahoo! Finance]
3/7
04:09 pm
mgnx
MacroGenics Provides Update on Corporate Progress and 2023 Financial Results [Yahoo! Finance]
High
Report
MacroGenics Provides Update on Corporate Progress and 2023 Financial Results [Yahoo! Finance]
3/7
04:01 pm
mgnx
MacroGenics Provides Update on Corporate Progress and 2023 Financial Results
High
Report
MacroGenics Provides Update on Corporate Progress and 2023 Financial Results
3/6
11:40 pm
mgnx
Insider Sell: COO Eric Risser Sells 41,159 Shares of Macrogenics Inc (MGNX) [Yahoo! Finance]
Medium
Report
Insider Sell: COO Eric Risser Sells 41,159 Shares of Macrogenics Inc (MGNX) [Yahoo! Finance]
3/4
08:06 am
mgnx
MacroGenics, Inc. (NASDAQ: MGNX) had its price target raised by analysts at BTIG Research from $12.00 to $24.00. They now have a "buy" rating on the stock.
Medium
Report
MacroGenics, Inc. (NASDAQ: MGNX) had its price target raised by analysts at BTIG Research from $12.00 to $24.00. They now have a "buy" rating on the stock.
3/2
08:20 am
mgnx
Are Investors Undervaluing MacroGenics, Inc. (NASDAQ:MGNX) By 48%? [Yahoo! Finance]
Medium
Report
Are Investors Undervaluing MacroGenics, Inc. (NASDAQ:MGNX) By 48%? [Yahoo! Finance]
3/1
05:48 pm
mgnx
MacroGenics to Participate in Upcoming Investor Conferences
Medium
Report
MacroGenics to Participate in Upcoming Investor Conferences
2/29
09:10 am
mgnx
MacroGenics, Inc. (NASDAQ: MGNX) had its price target raised by analysts at Barclays PLC from $12.00 to $23.00. They now have an "overweight" rating on the stock.
Medium
Report
MacroGenics, Inc. (NASDAQ: MGNX) had its price target raised by analysts at Barclays PLC from $12.00 to $23.00. They now have an "overweight" rating on the stock.
2/27
05:45 pm
mgnx
MacroGenics Announces Date of Fourth Quarter 2023 Financial Results Conference Call
Low
Report
MacroGenics Announces Date of Fourth Quarter 2023 Financial Results Conference Call
2/19
10:32 pm
mgnx
MacroGenics: Evaluating Its Buy Status After A 200% Surge On Prostate Cancer Prospects [Seeking Alpha]
Low
Report
MacroGenics: Evaluating Its Buy Status After A 200% Surge On Prostate Cancer Prospects [Seeking Alpha]
2/15
10:36 am
mgnx
MacroGenics: Trying To Build A Better Everything [Seeking Alpha]
Low
Report
MacroGenics: Trying To Build A Better Everything [Seeking Alpha]